Marek Wroński

Marek Wroński

Auto-generated profile, based on publicly available information

Marek Wroński

Department of General, Gastroenterological and Oncological Surgery, Medical University of Warsaw, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
Piotr RutkowskiPiotr Rutkowski
Piotr Rutkowski
EBE. Bylina
E. Bylina
AWAgnieszka Wozniak
Agnieszka Wozniak
ZNZ.I. Nowecki
Z.I. Nowecki
COC. Osuch
C. Osuch
HJHeikki Joensuu
Heikki Joensuu

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MWMarek Wronski
Marek Wronski
BZBogna Ziarkiewicz-Wroblewska
Bogna Ziarkiewicz-Wroblewska
BGBarbara Gornicka
Barbara Gornicka
WCWlodzimierz Cebulski
Wlodzimierz Cebulski
MSMaciej Slodkowski
Maciej Slodkowski
IKIreneusz W Krasnodebski
Ireneusz W Krasnodebski
AIM: To review clinical and pathologic features of Gas-trointestinal stromal tumors (GISTs) occurring synchro-nously with other primary gastrointestinal neoplasms. METHODS: Twenty-eight patients with primary GIST were treated at our institution between 1989 and 2005. Clinical and pathologic records were reviewed. RESULTS: The gastrointestinal stromal tumor occurred simultaneously with other primary GI malignancies in 14% of all patients with GIST. The synchronous stromal tumors were located in the stomach and were incidentally found during the operation. The coexistent neoplasms were colon adenocarcinoma, gastric cancer (2 cases) and gastric lymphoma. CONCLUSION: The synchronous occurrence of GISTs and other gastrointestinal malignancies is more common than it has been considered. The development of gastrointestinal stromal tumors and other neoplasms may involve the same carcinogenic agents.

1 January 2011 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MWMarek Wronski
Marek Wronski
To evaluate the management of pancreaticopleural fistulas involving early endoscopic instrumentation of the pancreatic duct. Eight patients with a spontaneous pancreaticopleural fistula underwent endoscopic retrograde cholangiopancreatography (ERCP) with an intention to stent the site of a ductal disruption as the primary treatment. Imaging features and management were evaluated retrospectively and compared with outcome. In one case, the stent bridged the site of a ductal disruption. The fistula in this patient closed within 3 wk. The main pancreatic duct in this case appeared normal, except for a leak located in the body of the pancreas. In another patient, the papilla of Vater could not be found and cannulation of the pancreatic duct failed. This patient underwent surgical treatment. In the remaining 6 cases, it was impossible to insert a stent into the main pancreatic duct properly so as to cover the site of leakage or traverse a stenosis situated downstream to the fistula. The placement of the stent failed because intraductal stones (n = 2) and ductal strictures (n = 2) precluded its passage or the stent was too short to reach the fistula located in the distal part of the pancreas (n = 2). In 3 out of these 6 patients, the pancreaticopleural fistula closed on further medical treatment. In these cases, the main pancreatic duct was normal or only mildly dilated, and there was a leakage at the body/tail of the pancreas. In one of these 3 patients, additional percutaneous drainage of the peripancreatic fluid collections allowed better control of the leakage and facilitated resolution of the fistula. The remaining 3 patients had a tight stenosis of the main pancreatic duct resistible to dilatation and the stent could not be inserted across the stenosis. Subsequent conservative treatment proved unsuccessful in these patients. After a failed therapeutic ERCP, 3 patients in our series developed superinfection of the pleural or peripancreatic fluid collections. Four out of 8 patients in our series required subsequent surgery due to a failed non-operative treatment. Distal pancreatectomy with splenectomy was performed in 3 cases. In one case, only external drainage of the pancreatic pseudocyst was done because of diffuse peripancreatic inflammatory infiltration precluding safe dissection. There were no perioperative mortalities. There was no recurrence of a pancreaticopleural fistula in any of the patients. Optimal management of pancreaticopleural fistulas requires appropriate patient selection that should be based on the underlying pancreatic duct abnormalities.

12 November 2010 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
MWMarek Wronski
Marek Wronski
MSMaciej Slodkowski
Maciej Slodkowski
WCWlodzimierz Cebulski
Wlodzimierz Cebulski
DKDominika Karkocha
Dominika Karkocha
IKIreneusz W. Krasnodebski
Ireneusz W. Krasnodebski

13 February 2013 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
MWMarek Wroński
Marek Wroński
WCWłodzimierz Cebulski
Włodzimierz Cebulski
DKDominika Karkocha
Dominika Karkocha
MSMaciej Słodkowski
Maciej Słodkowski
ŁWŁukasz Wysocki
Łukasz Wysocki
IKIreneusz W. Krasnodębski
Ireneusz W. Krasnodębski
Background The role of percutaneous drainage in the management of infected pancreatic necrosis remains controversial, and ultrasound-guided technique is rarely used for this indication. The purpose of this study was to evaluate the safety and efficacy of sonographically guided percutaneous catheter drainage for infected pancreatic necrosis. Methods The patient group consisted of 16 men and 2 women. The mean age of the patients was 47 years. The median computed tomography severity index of acute pancreatitis was 10 points. Percutaneous catheter drainage was performed under sonographic guidance using preferably retroperitoneal approach, and transperitoneal access in selected cases. The medical records and imaging scans were reviewed retrospectively for each patient. Results Percutaneous catheter drainage resulted in a complete resolution of infected pancreatic necrosis in 6 of 18 patients (33 %). Twelve of 18 patients who were initially managed with PCD required eventually necrosectomy (67 %). The most common reason for crossover to surgical intervention was persistent sepsis (n = 7). Open necrosectomy was performed in 4 of these patients, and 3 patients underwent successful minimally invasive retroperitoneal necrosectomy. Five patients required conversion to open surgery because of procedure-related complications. In 3 cases, there was leakage of the necrotic material into the peritoneal cavity. Two other patients experienced hemorrhagic complications. Overall mortality rate was 17 %. The size of the largest necrotic collection in patients who were successfully treated with percutaneous drainage decreased by a median of 76 % shortly after the procedure, whereas it decreased only by a median of 16 % in cases of failure of percutaneous drainage. Conclusions Ultrasound-guided percutaneous catheter drainage used in infected pancreatic necrosis is a technique with acceptably low morbidity and mortality that may be the definitive treatment or a bridge management to necrosectomy. A negligible decrease in size of the necrotic collection predicts failure of percutaneous drainage.

1 April 2017 in Journal of Surgical Research
Verified
Journal Article
Closed access
MWMarek Wroński
Marek Wroński
WCWłodzimierz Cebulski
Włodzimierz Cebulski
BWBartosz Witkowski
Bartosz Witkowski
MJMieczysław Jankowski
Mieczysław Jankowski
AKAndrzej Kluciński
Andrzej Kluciński
MSMaciej Słodkowski
Maciej Słodkowski